A pre-seed to Series B deep tech venture capital firm. We deploy capital and operator depth across artificial intelligence, life-sciences infrastructure, and the reindustrialization of America.
Two decades of running real businesses inform every check we write. For deep tech founders, that means an operating bench most funds can’t match: direct Asia market access, manufacturing and regulatory pattern recognition, and a live distribution motor. See how we partner →
Across artificial intelligence, biotech, aerospace, advanced materials, and beyond. A concentrated, active book of companies building what comes next.
Founders engage Yan Ventures and our operating partner at four levels of depth, determined by fit with our investment thesis and product catalog. See the full partnership model →
A working conversation with a team that has actually run the kind of business you’re building. Open to any company that reaches out.
Our operating partner’s sales team surveys real pharma, biotech, CRO, and CDMO buyers across Asia to test live demand.
Hands-on demos with end users at CDMOs and pharma companies in one of the world’s largest biopharma markets.
Our operating partner becomes your commercial motor across Asia: regulatory, logistics, sales, and customer success.
We hold concentrated, move at founder speed, and bring twenty years of operator depth across biopharma, manufacturing, and cross-border execution. If you’re building deep tech toward a long-term problem that matters, send us a paragraph. We respond the same week.
jesse [at] yanvc [dot] com